Linda J Sheu, MD
Dermatology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 33
- 8 carriers
- Office
- 1
Offices
1 location · Palo Alto Dermatology Institute · 6 clinicians in this group
Plans that list them
33 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sheu’s office at (650) 546-4929 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
33 of 33 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A112421 · Current
Licensed to practise in California · since 2010 · expires 2027-10-31 · Rosalind Franklin University, the Chicago Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$64,082
Medicare paid this office $64,082 for 135 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 102 | $20,657 | $112 |
| Destruction of skin growth, 1-14 growths | 32 | $5,259 | $107 |
| Destruction of precancer skin growth, 1 growth | 70 | $4,788 | $45 |
| Biopsy of related skin growth, first growth | 43 | $4,333 | $82 |
| Short return visit (20+ min) | 37 | $3,433 | $78 |
See all 9 services
| Return visit (30+ min) | 102 | $20,657 | $112 |
| Destruction of skin growth, 1-14 growths | 32 | $5,259 | $107 |
| Destruction of precancer skin growth, 1 growth | 70 | $4,788 | $45 |
| Biopsy of related skin growth, first growth | 43 | $4,333 | $82 |
| Short return visit (20+ min) | 37 | $3,433 | $78 |
| Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | 16 | $2,141 | $97 |
| New patient visit (45+ min) | 14 | $1,753 | $125 |
| Destruction of precancer skin growth, 2-14 growths | 45 | $1,715 | $7 |
| Biopsy of related skin growth, each additional growth | 11 | $728 | $52 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of skin lesions | 162 | More than 78% of doctors who do this |
| Removal or shaving of skin growth | 50 | More than 79% of doctors who do this |
| Skin biopsy | 118 | More than 78% of doctors who do this |
Who their Medicare patients are
135 Original Medicare patients in 2024. Average age 76 · Women 63% · Health risk score 0.88. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 61% · Coronary heart disease 21% · Atrial fibrillation 16% · Diabetes 13% · Cancer 13% · Depression 12% · Chronic kidney disease 10% · Stroke 9% · COPD 8%.
The office billed $145,495, Medicare allowed $84,964 and paid $64,082; for 1,154 services of 41 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 135 | 1,154 | 76 | 0.88 | $145,495 | $64,082 |
| 2023 | 135 | 818 | 76 | 0.88 | $135,746 | $62,855 |
| 2022 | 125 | 665 | 74 | 0.73 | $106,807 | $47,619 |
| 2021 | 133 | 713 | 77 | 0.99 | $96,200 | $47,153 |
| 2020 | 47 | 210 | 75 | 1.01 | $22,595 | $10,496 |
| 2019 | 416 | 2,208 | 75 | 1.06 | $553,800 | $115,140 |
| 2018 | 451 | 2,235 | 75 | 1.08 | $499,116 | $106,719 |
| 2017 | 405 | 1,673 | 75 | 1.07 | $417,456 | $86,965 |
| 2016 | 473 | 1,878 | 74 | 1.09 | $465,828 | $100,168 |
| 2015 | 468 | 2,387 | 74 | 1.10 | $577,393 | $118,800 |
| 2014 | 479 | 2,518 | 73 | 0.96 | $555,690 | $114,903 |
| 2013 | 463 | 2,437 | 73 | 1.06 | $501,845 | $108,171 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Return visit (30+ min) | 102 | $25,090 | $118 |
| Biopsy of related skin growth, first growth | 49 | $4,784 | $90 |
| Destruction of skin growth, 1-14 growths | 27 | $3,961 | $110 |
| Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm | 18 | $2,891 | $126 |
| Short return visit (20+ min) | 32 | $2,738 | $76 |
| New patient visit (45+ min) | 19 | $2,670 | $141 |
| Destruction of precancer skin growth, 1 growth | 48 | $2,622 | $42 |
| Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | 13 | $2,378 | $132 |
| Punch biopsy, first skin growth | 15 | $2,112 | $132 |
| Biopsy of related skin growth, each additional growth | 16 | $1,518 | $52 |
| Destruction of precancer skin growth, 2-14 growths | 36 | $1,245 | $7 |
2022: 10 services
| Return visit (30+ min) | 74 | $16,209 | $110 |
| Short return visit (20+ min) | 48 | $4,841 | $78 |
| Biopsy of related skin growth, first growth | 47 | $4,667 | $88 |
| Destruction of precancer skin growth, 1 growth | 51 | $3,227 | $50 |
| Punch biopsy, first skin growth | 15 | $2,277 | $127 |
| Destruction of skin growth, 1-14 growths | 18 | $2,176 | $95 |
| New patient visit (45+ min) | 16 | $1,697 | $106 |
| New patient visit (30+ min) | 14 | $1,133 | $81 |
| Destruction of precancer skin growth, 2-14 growths | 32 | $791 | $7 |
| Biopsy of related skin growth, each additional growth | 12 | $578 | $48 |
2021: 9 services
| Short return visit (20+ min) | 73 | $10,148 | $87 |
| Return visit (30+ min) | 53 | $8,951 | $126 |
| Biopsy of related skin growth, first growth | 46 | $5,671 | $105 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 13 | $4,404 | $315 |
| Destruction of precancer skin growth, 1 growth | 41 | $3,173 | $52 |
| New patient visit (30+ min) | 21 | $2,199 | $105 |
| Destruction of skin growth, 1-14 growths | 12 | $1,719 | $123 |
| Biopsy of related skin growth, each additional growth | 22 | $1,691 | $56 |
| Destruction of precancer skin growth, 2-14 growths | 30 | $1,327 | $7 |
2020: 4 services
| Short return visit (20+ min) | 25 | $2,002 | $69 |
| Biopsy of related skin growth, first growth | 15 | $1,522 | $95 |
| Destruction of precancer skin growth, 1 growth | 17 | $873 | $48 |
| Destruction of precancer skin growth, 2-14 growths | 13 | $600 | $6 |
2019: 14 services
| Short return visit (20+ min) | 292 | $19,901 | $54 |
| Biopsy of related skin growth, first growth | 156 | $13,818 | $76 |
| Return visit (30+ min) | 161 | $13,516 | $74 |
| Destruction of precancer skin growth, 1 growth | 226 | $11,713 | $41 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 38 | $11,109 | $258 |
| Destruction of skin growth, 1-14 growths | 69 | $6,506 | $87 |
| Destruction of precancer skin growth, 2-14 growths | 167 | $3,453 | $5 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | 15 | $3,341 | $223 |
| Biopsy of related skin growth, each additional growth | 45 | $3,023 | $45 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 24 | $2,762 | $106 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 17 | $2,177 | $121 |
| Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | 15 | $1,855 | $116 |
| New patient visit (30+ min) | 11 | $729 | $66 |
| Short return visit | 16 | $615 | $36 |
2018: 13 services
| Short return visit (20+ min) | 316 | $20,197 | $50 |
| Biopsy of single growth of skin and/or tissue | 185 | $16,853 | $79 |
| Return visit (30+ min) | 146 | $13,794 | $79 |
| Destruction of precancer skin growth, 1 growth | 212 | $10,922 | $39 |
| Destruction of skin growth, 1-14 growths | 82 | $8,151 | $88 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 29 | $7,218 | $233 |
| Destruction of precancer skin growth, 2-14 growths | 165 | $2,962 | $4 |
| Biopsy of each additional growth of skin and/or tissue | 53 | $1,857 | $27 |
| New patient visit (30+ min) | 25 | $1,829 | $73 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 13 | $1,661 | $119 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 14 | $1,458 | $104 |
| New patient visit (15+ min) | 15 | $808 | $54 |
| Short return visit | 22 | $732 | $33 |
2017: 14 services
| Short return visit (20+ min) | 288 | $17,772 | $48 |
| Biopsy of single growth of skin and/or tissue | 140 | $12,063 | $76 |
| Return visit (30+ min) | 90 | $7,332 | $74 |
| Destruction of precancer skin growth, 1 growth | 160 | $7,104 | $39 |
| Destruction of skin growth, 1-14 growths | 59 | $5,497 | $87 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 22 | $5,019 | $228 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 12 | $4,252 | $354 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 14 | $1,855 | $124 |
| Destruction of precancer skin growth, 2-14 growths | 96 | $1,786 | $4 |
| New patient visit (30+ min) | 25 | $1,739 | $70 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 13 | $1,525 | $117 |
| Biopsy of each additional growth of skin and/or tissue | 32 | $1,019 | $27 |
| Short return visit | 35 | $1,015 | $25 |
| Removal of skin tag, 1-15 skin tags | 11 | $533 | $48 |
2016: 16 services
| Short return visit (20+ min) | 313 | $20,037 | $50 |
| Biopsy of single growth of skin and/or tissue | 169 | $14,607 | $76 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 38 | $9,153 | $241 |
| Destruction of precancer skin growth, 1 growth | 161 | $8,232 | $41 |
| Return visit (30+ min) | 86 | $7,361 | $79 |
| Destruction of skin growth, 1-14 growths | 70 | $6,749 | $79 |
| New patient visit (30+ min) | 56 | $4,379 | $78 |
| Short return visit | 84 | $3,155 | $31 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | 13 | $2,657 | $190 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 20 | $2,161 | $108 |
| Destruction of precancer skin growth, 2-14 growths | 87 | $1,652 | $4 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 12 | $1,407 | $117 |
| Biopsy of each additional growth of skin and/or tissue | 36 | $1,329 | $26 |
| New patient visit (15+ min) | 24 | $1,151 | $48 |
| New patient visit (10+ min) | 14 | $432 | $31 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $175 | $15 |
2015: 18 services
| Short return visit (20+ min) | 353 | $25,763 | $50 |
| Biopsy of single growth of skin and/or tissue | 187 | $17,029 | $76 |
| Destruction of skin growth, 1-14 growths | 83 | $12,252 | $89 |
| Destruction of precancer skin growth, 1 growth | 211 | $11,231 | $40 |
| Return visit (30+ min) | 101 | $9,019 | $71 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 29 | $6,582 | $219 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | 19 | $4,225 | $201 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 11 | $3,361 | $306 |
| Destruction of precancer skin growth, 2-14 growths | 154 | $3,157 | $5 |
| Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm | 11 | $2,253 | $188 |
| Short return visit | 54 | $2,064 | $32 |
| New patient visit (30+ min) | 29 | $2,021 | $70 |
| Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | 14 | $1,795 | $120 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 12 | $1,636 | $117 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 14 | $1,498 | $107 |
| Biopsy of each additional growth of skin and/or tissue | 42 | $1,338 | $27 |
| New patient visit (15+ min) | 12 | $712 | $59 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $217 | $17 |
2014: 15 services
| Short return visit (20+ min) | 336 | $24,600 | $50 |
| Biopsy of single growth of skin and/or tissue | 175 | $14,907 | $76 |
| Destruction of precancer skin growth, 1 growth | 216 | $13,042 | $46 |
| Destruction of skin growth, 1-14 growths | 79 | $8,744 | $83 |
| New patient visit (30+ min) | 110 | $8,487 | $77 |
| Destruction of precancer skin growth, 2-14 growths | 163 | $7,163 | $8 |
| Return visit (30+ min) | 46 | $3,806 | $81 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 14 | $2,936 | $210 |
| Short return visit | 77 | $2,746 | $31 |
| Destruction of precancer skin growth, 15 or more growths | 18 | $2,510 | $120 |
| Biopsy of each additional growth of skin and/or tissue | 59 | $2,135 | $26 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 12 | $1,492 | $115 |
| New patient visit (15+ min) | 16 | $852 | $53 |
| New patient visit (10+ min) | 11 | $225 | $20 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $199 | $17 |
2013: 14 services
| Short return visit (20+ min) | 264 | $19,879 | $52 |
| Biopsy of single growth of skin and/or tissue | 163 | $14,705 | $81 |
| Destruction of precancer skin growth, 1 growth | 207 | $12,757 | $50 |
| Destruction of skin growth, 1-14 growths | 80 | $9,654 | $90 |
| New patient visit (30+ min) | 103 | $7,856 | $76 |
| Short return visit | 120 | $5,769 | $32 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 22 | $5,030 | $229 |
| Destruction of precancer skin growth, 2-14 growths | 157 | $4,274 | $5 |
| New patient visit (15+ min) | 42 | $2,177 | $52 |
| Destruction of precancer skin growth, 15 or more growths | 15 | $2,170 | $136 |
| New patient visit (10+ min) | 68 | $1,950 | $29 |
| Biopsy of each additional growth of skin and/or tissue | 52 | $1,948 | $26 |
| Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | 11 | $1,630 | $136 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 50 | $818 | $14 |
Drugs they prescribed that Part D paid
$131,385
Pharmacies billed $131,385 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 296) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
274 generic and 22 brand-name prescriptions · $131,385 in drug cost · 21 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Fluocinonide | 28 | $1,392 | $50 |
| Betamethasone Dipropionate | 15 | $679 | $45 |
| Ketoconazole | 43 | $513 | $12 |
| Imiquimod | 11 | $398 | $36 |
| Triamcinolone Acetonide | 39 | $304 | $8 |
See all 8 drugs
| Fluocinonide | 28 | $1,392 | $50 |
| Betamethasone Dipropionate | 15 | $679 | $45 |
| Ketoconazole | 43 | $513 | $12 |
| Imiquimod | 11 | $398 | $36 |
| Triamcinolone Acetonide | 39 | $304 | $8 |
| Mupirocin | 25 | $267 | $11 |
| Doxycycline Hyclate | 13 | $247 | $19 |
| Spironolactone | 14 | $93 | $7 |
Year by year
| 2024 | 296 | 105 | 0% (0) | 7% | $131,385 |
| 2023 | 213 | 79 | 0% (0) | None | $7,951 |
| 2022 | 138 | 52 | 0% (0) | None | $7,575 |
| 2021 | 116 | 51 | 0% (0) | None | $7,110 |
| 2020 | 169 | 80 | 0% (0) | 7% | $13,564 |
| 2019 | 599 | 224 | 0% (0) | 8% | $30,316 |
| 2018 | 641 | 255 | None | 10% | $43,240 |
| 2017 | 683 | 238 | 0% (0) | 12% | $43,623 |
| 2016 | 903 | 296 | 0% (0) | 14% | $65,514 |
| 2015 | 751 | 251 | None | 13% | $59,539 |
| 2014 | 816 | 301 | None | 17% | $61,250 |
| 2013 | 854 | 279 | None | 14% | $62,431 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Fluorouracil | 12 | $1,109 | $92 |
| Fluocinonide | 21 | $941 | $45 |
| Ketoconazole | 32 | $659 | $21 |
| Doxycycline Hyclate | 20 | $647 | $32 |
| Mupirocin | 20 | $300 | $15 |
| Triamcinolone Acetonide | 21 | $294 | $14 |
| Prednisone | 15 | $93 | $6 |
2022: 4 drugs
| Fluocinonide | 12 | $701 | $58 |
| Triamcinolone Acetonide | 26 | $382 | $15 |
| Ketoconazole | 17 | $348 | $20 |
| Mupirocin | 11 | $121 | $11 |
2021: 3 drugs
| Estradiol (Twice Weekly) | 13 | $909 | $70 |
| Mupirocin | 15 | $179 | $12 |
| Triamcinolone Acetonide | 14 | $159 | $11 |
2020: 6 drugs
| Doxycycline Hyclate | 16 | $2,144 | $134 |
| Spironolactone | 17 | $940 | $55 |
| Estradiol (Twice Weekly) | 12 | $836 | $70 |
| Fluocinonide | 11 | $604 | $55 |
| Ketoconazole | 14 | $401 | $29 |
| Triamcinolone Acetonide | 21 | $338 | $16 |
2019: 13 drugs
| Fluorouracil | 45 | $4,269 | $95 |
| Fluocinonide | 49 | $2,875 | $59 |
| Doxycycline Hyclate | 51 | $2,142 | $42 |
| Clobetasol Propionate | 34 | $1,984 | $58 |
| Clindamycin Phosphate | 32 | $1,482 | $46 |
| Ketoconazole | 54 | $1,266 | $23 |
| Spironolactone | 26 | $1,076 | $41 |
| Triamcinolone Acetonide | 82 | $966 | $12 |
| Fluconazole | 14 | $276 | $20 |
| Nystop | 15 | $219 | $15 |
| Gabapentin | 12 | $178 | $15 |
| Glycopyrrolate | 11 | $128 | $12 |
| Prednisone | 12 | $49 | $4 |
2018: 18 drugs
| Clobetasol Propionate | 59 | $7,241 | $123 |
| Fluorouracil | 45 | $4,956 | $110 |
| Doxycycline Hyclate | 60 | $3,230 | $54 |
| Clindamycin Phosphate | 38 | $2,500 | $66 |
| Ketoconazole | 53 | $1,719 | $32 |
| Fluocinonide | 22 | $1,695 | $77 |
| Metronidazole | 16 | $1,341 | $84 |
| Triamcinolone Acetonide | 75 | $1,172 | $16 |
| Desonide | 12 | $1,104 | $92 |
| Methotrexate | 17 | $1,067 | $63 |
| Betamethasone Dipropionate | 16 | $874 | $55 |
| Clotrimazole-Betamethasone | 15 | $710 | $47 |
| Spironolactone | 23 | $635 | $28 |
| Fluconazole | 22 | $493 | $22 |
| Betamethasone Diprop Augmented | 13 | $465 | $36 |
| Minocycline | 13 | $432 | $33 |
| Prednisone | 12 | $70 | $6 |
| Hydrocortisone | 11 | $49 | $4 |
2017: 16 drugs
| Clobetasol Propionate | 63 | $10,324 | $164 |
| Fluorouracil | 29 | $3,012 | $104 |
| Fluocinonide | 44 | $2,976 | $68 |
| Clindamycin Phosphate | 28 | $2,219 | $79 |
| Methotrexate | 23 | $1,901 | $83 |
| Ketoconazole | 57 | $1,765 | $31 |
| Doxycycline Hyclate | 48 | $1,623 | $34 |
| Metronidazole | 12 | $1,431 | $119 |
| Triamcinolone Acetonide | 97 | $1,143 | $12 |
| Betamethasone Dipropionate | 12 | $691 | $58 |
| Fluconazole | 33 | $506 | $15 |
| Hydroxyzine | 17 | $470 | $28 |
| Clotrimazole | 11 | $446 | $41 |
| Clotrimazole-Betamethasone | 12 | $429 | $36 |
| Prednisone | 26 | $213 | $8 |
| Spironolactone | 17 | $172 | $10 |
2016: 18 drugs
| Clobetasol Propionate | 116 | $21,349 | $184 |
| Fluorouracil | 59 | $7,160 | $121 |
| Fluocinonide | 54 | $4,046 | $75 |
| Doxycycline Hyclate | 52 | $2,889 | $56 |
| Ketoconazole | 75 | $2,793 | $37 |
| Triamcinolone Acetonide | 107 | $2,533 | $24 |
| Metronidazole | 12 | $1,494 | $125 |
| Mycophenolate Mofetil | 23 | $1,143 | $50 |
| Clotrimazole | 20 | $891 | $45 |
| Clindamycin Phosphate | 14 | $877 | $63 |
| Clotrimazole-Betamethasone | 23 | $870 | $38 |
| Betamethasone Dipropionate | 15 | $549 | $37 |
| Methotrexate | 17 | $535 | $31 |
| Hydroxyzine | 25 | $506 | $20 |
| Prednisone | 52 | $502 | $10 |
| Fluconazole | 25 | $311 | $12 |
| Cephalexin | 28 | $123 | $4 |
| Sulfamethoxazole-Trimethoprim | 18 | $83 | $5 |
2015: 18 drugs
| Clobetasol Propionate | 110 | $22,228 | $202 |
| Fluorouracil | 32 | $4,932 | $154 |
| Doxycycline Hyclate | 59 | $4,702 | $80 |
| Metronidazole | 29 | $3,466 | $120 |
| Ketoconazole | 75 | $1,774 | $24 |
| Clindamycin Phosphate | 23 | $1,554 | $68 |
| Triamcinolone Acetonide | 106 | $1,458 | $14 |
| Betamethasone Dipropionate | 34 | $1,379 | $41 |
| Clotrimazole-Betamethasone | 17 | $989 | $58 |
| Mycophenolate Mofetil | 12 | $852 | $71 |
| Betamethasone Dipropionate | 23 | $798 | $35 |
| Methotrexate | 12 | $790 | $66 |
| Hydroxyzine | 27 | $566 | $21 |
| Fluconazole | 14 | $378 | $27 |
| Prednisone | 23 | $226 | $10 |
| Gabapentin | 11 | $112 | $10 |
| Cephalexin | 25 | $92 | $4 |
| Sulfamethoxazole-Trimethoprim | 13 | $50 | $4 |
2014: 16 drugs
| Fluorouracil | 63 | $10,465 | $166 |
| Clobetasol Propionate | 137 | $10,095 | $74 |
| Doxycycline Hyclate | 62 | $4,812 | $78 |
| Metronidazole | 33 | $4,170 | $126 |
| Fluocinolone Acetonide | 15 | $2,595 | $173 |
| Triamcinolone Acetonide | 103 | $2,291 | $22 |
| Mycophenolate Mofetil | 14 | $1,490 | $106 |
| Clindamycin Phosphate | 20 | $1,358 | $68 |
| Clotrimazole-Betamethasone | 38 | $1,354 | $36 |
| Clobetasol Emollient | 21 | $1,318 | $63 |
| Ketoconazole | 83 | $1,293 | $16 |
| Fluocinonide | 12 | $792 | $66 |
| Betamethasone Dipropionate | 13 | $603 | $46 |
| Hydroxyzine | 26 | $584 | $22 |
| Prednisone | 20 | $304 | $15 |
| Cephalexin | 23 | $137 | $6 |
2013: 18 drugs
| Fluorouracil | 67 | $12,451 | $186 |
| Clobetasol Propionate | 122 | $4,014 | $33 |
| Triamcinolone Acetonide | 124 | $2,753 | $22 |
| Betamethasone Dipropionate | 33 | $2,317 | $70 |
| Doxycycline Hyclate | 39 | $2,222 | $57 |
| Metronidazole | 14 | $1,781 | $127 |
| Ketoconazole | 73 | $1,588 | $22 |
| Clotrimazole-Betamethasone | 28 | $1,581 | $56 |
| Clobetasol Emollient | 27 | $1,262 | $47 |
| Fluocinolone Acetonide | 19 | $1,217 | $64 |
| Fluocinonide | 16 | $1,042 | $65 |
| Methotrexate | 11 | $911 | $83 |
| Betamethasone Dipropionate | 14 | $805 | $58 |
| Hydroxyzine | 32 | $492 | $15 |
| Ciclopirox | 11 | $355 | $32 |
| Prednisone | 36 | $191 | $5 |
| Minocycline | 14 | $144 | $10 |
| Cephalexin | 21 | $102 | $5 |
Money from drug and device companies
$1,605 in 2025
| 2025 | 15 | 64 | None | $1,605 |
| 2024 | 14 | 59 | None | $1,471 |
| 2023 | 13 | 39 | None | $1,022 |
| 2022 | 10 | 33 | None | $693 |
| 2021 | 5 | 11 | None | $253 |
| 2020 | 7 | 11 | None | $228 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Rinvoq | $349 | 16 payments
|
| Regeneron Healthcare Solutions | Dupixent | $330 | 15 payments
|
| Genzyme | Dupixent | $239 | 7 payments
|
| Arcutis Biotherapeutics | Zoryve | $167 | 7 payments
|
| LEO Pharma | Adbry | $111 | 4 payments
|
| Lilly USA | Taltz | $80 | 3 payments
|
See all 64 published payments
| Abbvie | Meals · 2025-12-19 | Skyrizi | $16 |
| Galderma Laboratories L.P. | Meals · 2025-12-18 | Nemluvio | $29 |
| Regeneron Healthcare Solutions | Meals · 2025-12-16 | Dupixent | $10 |
| Regeneron Healthcare Solutions | Meals · 2025-12-16 | Libtayo | $37 |
| Regeneron Healthcare Solutions | Education · 2025-12-04 | Dupixent | $98 |
| Novartis Pharmaceuticals | Meals · 2025-12-01 | Cosentyx | $23 |
| Abbvie | Meals · 2025-11-24 | Rinvoq | $30 |
| LEO Pharma | Meals · 2025-11-13 | Anzupgo | $24 |
| Abbvie | Meals · 2025-11-11 | Skyrizi | $25 |
| Regeneron Healthcare Solutions | Meals · 2025-11-04 | Dupixent | $24 |
| Genzyme | Meals · 2025-10-27 | Dupixent | $38 |
| LEO Pharma | Meals · 2025-10-24 | Adbry | $29 |
| Arcutis Biotherapeutics | Meals · 2025-10-20 | Zoryve | $24 |
| Abbvie | Meals · 2025-10-16 | Rinvoq | $31 |
| Pfizer | Meals · 2025-10-13 | Xeljanz | $22 |
| Regeneron Healthcare Solutions | Meals · 2025-10-09 | Dupixent | $22 |
| Genzyme | Meals · 2025-09-29 | Dupixent | $38 |
| Abbvie | Meals · 2025-09-26 | Skyrizi | $11 |
| LEO Pharma | Meals · 2025-09-26 | Adbry | $28 |
| Janssen Biotech | Meals · 2025-09-18 | Tremfya | $28 |
| Organon | Meals · 2025-09-08 | Vtama | $27 |
| Regeneron Healthcare Solutions | Meals · 2025-08-26 | Dupixent | $15 |
| Arcutis Biotherapeutics | Meals · 2025-08-25 | Zoryve | $20 |
| Verrica Pharmaceuticals | Meals · 2025-08-14 | Ycanth | $23 |
| Lilly USA | Meals · 2025-08-08 | Taltz | $22 |
| Abbvie | Meals · 2025-08-08 | Rinvoq | $33 |
| LEO Pharma | Meals · 2025-07-28 | Adbry | $30 |
| Genzyme | Meals · 2025-07-21 | Dupixent | $36 |
| Arcutis Biotherapeutics | Meals · 2025-07-03 | Zoryve | $24 |
| Regeneron Healthcare Solutions | Meals · 2025-07-01 | Dupixent | $14 |
| Abbvie | Meals · 2025-06-30 | Rinvoq | $21 |
| Incyte | Meals · 2025-06-17 | Opzelura | $29 |
| Galderma Laboratories L.P. | Meals · 2025-06-10 | Nemluvio | $31 |
| Abbvie | Education · 2025-06-02 | Skyrizi | $10 |
| Lilly USA | Meals · 2025-05-22 | Ebglyss | $29 |
| Sun Pharmaceutical Industries | Meals · 2025-05-21 | Winlevi | $27 |
| Regeneron Healthcare Solutions | Meals · 2025-05-20 | Dupixent | $15 |
| Abbvie | Meals · 2025-05-13 | Rinvoq | $26 |
| Arcutis Biotherapeutics | Meals · 2025-05-09 | Zoryve | $22 |
| Regeneron Healthcare Solutions | Meals · 2025-05-03 | Dupixent | $25 |
| Genzyme | Meals · 2025-04-28 | Dupixent | $35 |
| Lilly USA | Meals · 2025-04-24 | Taltz | $29 |
| Abbvie | Meals · 2025-04-22 | Rinvoq | $23 |
| Janssen Biotech | Meals · 2025-04-14 | Tremfya | $31 |
| Arcutis Biotherapeutics | Meals · 2025-04-03 | Zoryve | $28 |
| Abbvie | Meals · 2025-04-01 | Skyrizi | $29 |
| Abbvie | Meals · 2025-03-25 | Skyrizi | $14 |
| Regeneron Healthcare Solutions | Meals · 2025-03-25 | Dupixent | $12 |
| Abbvie | Meals · 2025-03-21 | Rinvoq | $17 |
| Arcutis Biotherapeutics | Meals · 2025-03-13 | Zoryve | $25 |
| Regeneron Healthcare Solutions | Meals · 2025-03-11 | Dupixent | $11 |
| Abbvie | Meals · 2025-03-07 | Skyrizi | $29 |
| Genzyme | Meals · 2025-03-03 | Dupixent | $36 |
| Regeneron Healthcare Solutions | Meals · 2025-02-11 | Dupixent | $25 |
| Regeneron Healthcare Solutions | Meals · 2025-01-31 | Dupixent | $7 |
| Regeneron Healthcare Solutions | Meals · 2025-01-31 | Dupixent | $4 |
| Regeneron Healthcare Solutions | Meals · 2025-01-28 | Dupixent | $10 |
| Organon | Meals · 2025-01-28 | Vtama | $31 |
| Abbvie | Meals · 2025-01-24 | Rinvoq | $26 |
| Abbvie | Meals · 2025-01-13 | Skyrizi | $12 |
| Arcutis Biotherapeutics | Meals · 2025-01-13 | Zoryve | $24 |
| Genzyme | Meals · 2025-01-10 | Dupixent | $18 |
| Almirall | Meals · 2025-01-09 | Klisyri | $28 |
| Genzyme | Meals · 2025-01-06 | Dupixent | $37 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $1,471
| Abbvie | Rinvoq | $415 | 16 payments
|
| Regeneron Healthcare Solutions | Dupixent | $247 | 11 payments
|
| Genzyme | Dupixent | $155 | 5 payments
|
| Lilly USA | Taltz | $143 | 5 payments
|
| LEO Pharma | Adbry | $135 | 6 payments
|
| Novartis Pharmaceuticals | Cosentyx | $87 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $64 | 2 payments
|
| Pfizer | Eucrisa | $56 | 3 payments
|
| Dermavant Sciences | Vtama | $45 | 2 payments
|
| Sun Pharmaceutical Industries | Ilumya | $33 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $32 | 1 payment
|
| Biofrontera | Ameluz | $24 | 1 payment
|
| Galderma Laboratories L.P. | None | $22 | 1 payment
|
| Janssen Biotech | Tremfya | $13 | 1 payment
|
2023: $1,022
| Genzyme | Dupixent | $220 | 7 payments
|
| Lilly USA | Taltz | $142 | 5 payments
|
| AbbVie | Rinvoq | $142 | 5 payments
|
| LEO Pharma | Adbry | $140 | 6 payments
|
| Novartis Pharmaceuticals | Cosentyx | $89 | 4 payments
|
| Sun Pharmaceutical Industries | Ilumya | $56 | 2 payments
|
| Dermavant Sciences | Vtama | $51 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $45 | 2 payments
|
| Pfizer | Cibinqo | $43 | 2 payments
|
| Krystal Biotech | Vyjuvek | $32 | 1 payment
|
| Incyte | Opzelura | $23 | 1 payment
|
| STRATA Skin Sciences | Xtrac | $21 | 1 payment
|
| Janssen Biotech | Remicade | $20 | 1 payment
|
2022: $693
| LEO Pharma | Adbry | $180 | 10 payments
|
| Abbvie | Skyrizi | $170 | 8 payments
|
| Regeneron Healthcare Solutions | Dupixent | $81 | 3 payments
|
| Genzyme | Dupixent | $60 | 2 payments
|
| Janssen Biotech | Remicade | $55 | 3 payments
|
| Sun Pharmaceutical Industries | Ilumya | $51 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $38 | 2 payments
|
| Lilly USA | Taltz | $20 | 1 payment
|
| Almirall | Klisyri | $19 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $18 | 1 payment
|
2021: $253
| Novartis Pharmaceuticals | Cosentyx | $68 | 3 payments
|
| LEO Pharma | Enstilar | $62 | 3 payments
|
| AbbVie | Skyrizi | $52 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $50 | 2 payments
|
| Genzyme | Dupixent | $22 | 1 payment
|
2020: $228
| AbbVie | Skyrizi | $58 | 3 payments
|
| Genzyme | Dupixent | $49 | 2 payments
|
| Pfizer | Eucrisa | $37 | 2 payments
|
| Sun Pharmaceutical Industries | Ilumya | $22 | 1 payment
|
| VYNE Pharmaceuticals | Amzeeq | $21 | 1 payment
|
| Janssen Biotech | Remicade | $21 | 1 payment
|
| Lilly USA | Taltz | $20 | 1 payment
|
Professional record
- NPI
- 1114182920
- Licence
- CA A112421, IL 4649604 A138California A112421: Current · expires 2027-10-31
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 10470 Old Placerville Rd, Suite 100, Sacramento, CA, 95827
- NPI first listed
- 2008-07-21
- NPI last updated
- 2015-07-29
This is when the NPI record was last certified, not a medical board exam.